Learning Objectives:

  1. Appreciate the controversies regarding the immune vs islet pathogenesis of type 1 diabetes.
  2. Recognize new perspectives on residual beta cells in type 1 diabetes.
  3. Appreciate the rationale underlying new approaches for the treatment of type 1 diabetes
Session date: 
04/01/2022 - 12:00pm to 1:00pm CDT
Location: 
Zoom meeting
5841 S MARYLAND AVE
Chicago, IL 606371443
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Raghu Mirmira, MD, PhD